IBS and Chronic Constipation Journal Articles

 
 
  • Vancomycin for Primary Sclerosing Cholangitis This review summarizes the current evidence on the use of vancomycin in the treatment of primary sclerosing cholangitis and explores future research areas of interest.
  • Fibrosis in Ulcerative Colitis and Mucosal Inflammation This study investigated ulcerative colitis-associated fibrosis and its possible link to clinical parameters.
  • Multiple Myeloma With Severe Abdominal Pain and Diarrhea In this unusual case, diarrhea and abdominal pain were the initial presenting symptoms of multiple myeloma with a plasmacytoma.
  • The Impact of Genitourinary Syndrome of Menopause on QoL Genitourinary syndrome of menopause can negatively impact quality of life. How can clinicians help support these patients?
  • Opioid Use in GI Diagnoses vs Unexplained GI Symptoms How does the opioid prescription rate compare between patients with unexplained gastrointestinal symptoms and those with structural diagnoses?
  • Celiac Disease in Later Life Must Not Be Missed Celiac disease may manifest at any age. How prevalent is it in older persons, and how might symptoms present?
  • Intrathecal Morphine and Postop Pain in Knee Arthroplasty Is intrathecal morphine effective in reducing postoperative pain in total knee arthroplasty patients? How does it impact circulating levels of analgesic endocannabinoids?
  • Diverticular Disease: The Ever-Changing View This review updates current understanding of the epidemiology and risk factors for diverticular disease. What progress has been made in prophylaxis and therapy?
  • Dietary Change as a Treatment Strategy for Skin Disease This review focuses on five major skin conditions for which dietary change may contribute to treatment--both by eliminating "triggers" and providing benefit.
  • Long-term Effects of Fecal Transplant in Recurrent C. Diff Treatment of recurrent C. difficile infection with fecal microbiota transplantation has been shown to be safe in the short term, but might there be long-term adverse effects?
  • Yoga vs a Low-FODMAP Diet in Patients With IBS Might a yoga-based intervention or a low-FODMAP diet improve symptoms in patients with irritable bowel syndrome?
  • Implications of Dietary Interventions for GI Disorders Therapeutic diets, such as low FODMAP, high-fiber, or gluten-free, are increasingly being used in the management of gastrointestinal disorders. Might they negatively impact nutrition?
  • New Therapies in IBS: What Works and When This review examines the evidence supporting both traditional and recently developed therapies for irritable bowel syndrome. What should be first-line therapy?
  • Therapeutic Drug Monitoring of Anti-TNF Therapy in IBD The authors present multiple consensus statements which support and detail the role of therapeutic drug monitoring in optimizing the use of anti-TNF agents in modern IBD management.
  • Geriatric Anorexia Nervosa This case of a 66-year-old woman with anorexia nervosa underscores the need to recognize eating disorders among older people, which can be associated with significant psychiatric comorbidities.
  • Management of Sexual Problems: The Approach of Mindfulness This review examines the application of mindfulness-based interventions to the treatment of sexual problems. How might mindfulness benefit sexual health and well-being?
  • Fecal Microbiota Transplant for Refractory C. Difficile This meta-analysis aimed to systematically evaluate the effectiveness of fecal microbiota transplantation as treatment for recurrent and refractory C. difficile infection.
  • Sham Opioids Relieve Aspects of Chronic Back Pain Recent studies indicate that patients suffering from pain disorders respond positively to placebo. Should placebos be a legitimate treatment option to prescribe for pain?
  • The Rise of Anaphylaxis to Plant Foods This review examines the role of fruits and vegetables in allergy prevention -- and looks at which ones may cause severe allergic reactions.
  • Intestinal Microbiome in Scleroderma How has our understanding of the involvement of intestinal microbiome in scleroderma recently evolved?